Bray Jenelle K, Goddard William A
Materials and Process Simulation Center, California Institute of Technology, Pasadena, CA 91125, United States.
J Mol Graph Model. 2008 Aug;27(1):66-81. doi: 10.1016/j.jmgm.2008.02.006. Epub 2008 Mar 27.
We used the MembStruk computational procedure to predict the three-dimensional (3D) structure for the serotonin 5-HT(2C) G-protein-coupled receptor (GPCR). Using this structure, we used the MSCDock computational procedure to predict the 3D structures for bound ligand-protein complexes for agonists such as serotonin and antagonists such as ritanserin, metergoline, and methiothepin. In addition, we predicted the SAR data for a series of psilocybin analogs, both agonists and antagonists. We performed molecular dynamics (MD) on serotonin bound to 5-HT(2C) and we find the protein and binding site to be stable after 5ns. We find good agreement with the currently known experimental data and we predict a number of new mutations which could be used to validate further our predicted structures. This agreement between theory and experiment suggests that our 3D structure is sufficiently accurate for use in drug design. We also compare a preliminary prediction for 5-HT(2B) with our prediction for 5-HT(2C) and find a difference in TM5 that contributes to different serotonin binding modes in 5-HT(2B) and 5-HT(2C).
我们使用MembStruk计算程序来预测血清素5-HT(2C) G蛋白偶联受体(GPCR)的三维(3D)结构。利用该结构,我们使用MSCDock计算程序来预测诸如血清素等激动剂以及诸如利坦色林、美替拉林和甲硫噻平之类拮抗剂的结合配体-蛋白质复合物的3D结构。此外,我们预测了一系列裸盖菇素类似物(包括激动剂和拮抗剂)的构效关系(SAR)数据。我们对与5-HT(2C)结合的血清素进行了分子动力学(MD)模拟,发现在5纳秒后蛋白质和结合位点是稳定的。我们发现与目前已知的实验数据吻合良好,并预测了一些新的突变,可用于进一步验证我们预测的结构。理论与实验之间的这种吻合表明,我们的3D结构对于药物设计而言足够准确。我们还将5-HT(2B)的初步预测结果与5-HT(2C)的预测结果进行了比较,发现跨膜螺旋5(TM5)存在差异,这导致了5-HT(2B)和5-HT(2C)中血清素结合模式的不同。